< Back to all Breaking News
ARMP
5/23/2022 08:05am
Armata Pharmaceuticals doses first patient in Phase 1b/2a study of AP-SA02
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.